In this episode, EFCCA Innovation and Patient Engagement Coordinator Roberto Saldaña and EFCCA CEO Luisa Avedano share their views on the OmiCrohn clinical trial and reflect on the potential impact it may have on the lives of people living with Crohn’s disease.
Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice.